Insights into the pathogenesis of allergic disease from dedicator of cytokinesis 8 deficiency

Curr Opin Immunol. 2023 Feb:80:102277. doi: 10.1016/j.coi.2022.102277. Epub 2022 Dec 9.

Abstract

Clinical observations and mechanistic studies in dedicator of cytokinesis 8 (DOCK8)-deficient patients and mice have revealed multiple mechanisms that could contribute to their unusually prevalent and severe allergic disease manifestations. Physical interactions of DOCK8 with STAT3 in B cells and T cells may contribute to increased IgE isotype switching or defective immune synapse formation that decreases T-cell receptor signal strength. A newly discovered TFH13 cell type promotes the development of life-threatening allergy via production of IL-13 and is increased in DOCK8 deficiency. Cytoskeletal derangements and cytothripsis, which were previously shown to account for the increased susceptibility to viral skin infection in DOCK8 deficiency, can lead to interplay between myeloid cells and T cells to ultimately increase production of IL-4, IL-5, and IL-13. Finally, the effects on type-2 innate lymphoid cells may also contribute to allergic disease.

Publication types

  • Review
  • Research Support, N.I.H., Intramural

MeSH terms

  • Animals
  • Cytokinesis
  • Guanine Nucleotide Exchange Factors* / genetics
  • Guanine Nucleotide Exchange Factors* / metabolism
  • Hypersensitivity*
  • Immunity, Innate
  • Immunologic Deficiency Syndromes
  • Interleukin-13
  • Lymphocytes / metabolism
  • Mice

Substances

  • Dock8 protein, mouse
  • Guanine Nucleotide Exchange Factors
  • Interleukin-13
  • DOCK8 protein, human